Investigation of 6-[18F]-fluoromaltose as a novel PET tracer for imaging bacterial infection

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Gowrishankar, Gayatri ^a   Namavari, Mohammad ^a   Jouannot, Erwan Benjamin ^b   Hoehne, Aileen ^a   Reeves, Robert ^a   Hardy, Jonathan ^a   Gambhir, Sanjiv Sam ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUOROMALTOSE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; FLUORINE; MALTOSE;

ABSCESS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL MYOSITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL SPECIFICITY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG RETENTION; DRUG SYNTHESIS; DRUG UPTAKE; ESCHERICHIA COLI; HISTOPATHOLOGY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; MICRO COMPUTER ASSISTED EMISSION TOMOGRAPHY; MOUSE; MURINE MODEL; MYOSITIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; ANIMAL; NUDE MOUSE; SCINTISCANNING;

BACTERIA (MICROORGANISMS);

ANIMALS; BACTERIAL INFECTIONS; FLUORINE RADIOISOTOPES; MALTOSE; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84907907752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107951     Document Type: Article

References (21)

1. 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med 46: 567-573.
2. 99m)Tc-ciprofloxacin (Infecton). J Clin Pathol 55: 817-823.
3. Bunschoten A, Welling MM, Termaat MF, Sathekge M, van Leeuwen FW (2013) Development and prospects of dedicated tracers for the molecular imaging of bacterial infections. Bioconjug Chem 24: 1971-1989.
4. 99m human immunoglobulin (HIG): a new substance for scintigraphic detection of bone and joint infections. Microsurgery 17: 272-277.
5. Sasser TA, Van Avermaete AE, White A, Chapman S, Johnson JR, et al. (2013) Bacterial infection probes and imaging strategies in clinical nuclear medicine and preclinical molecular imaging. Curr Top Med Chem 13: 479-487.
6. Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, et al. (2004) Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303: 851-853.
7. Leevy WM, Serazin N, Smith BD (2007) Optical Imaging of Bacterial Infection Models. Drug Discov Today Dis Models 4: 91-97.
8. van Oosten M, Schafer T, Gazendam JA, Ohlsen K, Tsompanidou E, et al. (2013) Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat Commun 4: 2584.
9. Tang EN, Nair A, Baker DW, Hu W, Zhou J (2014) In vivo imaging of infection using a bacteria-targeting optical nanoprobe. J Biomed Nanotechnol 10: 856-863.
10. 18)F]fluoroalkylated ciprofloxacin as a potential bacterial infection imaging agent for PET study. Bioconjug Chem 21: 2282-2288.
11. 124I]FIAU-PET/CT. PLoS One 2: e1007.
12. 14C-FIAU to predict bacterial thymidine kinase presence: implications for radiolabeled FIAU bacterial imaging. Nucl Med Biol 40: 638-642.
13. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection. J Nucl Med 45: 849-856.
14. Ning X, Lee S, Wang Z, Kim D, Stubblefield B, et al. (2011) Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat Mater 10: 602-607.
15. Ferenci T (1980) The recognition of maltodextrins by Escherichia coli. Eur J Biochem 108: 631-636.
16. Jones SA, Jorgensen M, Chowdhury FZ, Rodgers R, Hartline J, et al. (2008) Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine. Infect Immun 76: 2531-2540.
17. Shelburne SA 3rd, Sumby P, Sitkiewicz I, Okorafor N, Granville C, et al. (2006) Maltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynx. Infect Immun 74: 4605-4614.
18. James ML, Gambhir SS (2012) A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 92: 897-965.
19. 18F]-labelled Maltose Derivatives as PET Tracers for Imaging Bacterial Infection Molecular Imaging and Biology.
20. Landau BR, Spring-Robinson CL, Muzic RF, Jr., Rachdaoui N, Rubin D, et al. (2007) 6-Fluoro-6-deoxy-D-glucose as a tracer of glucose transport. Am J Physiol Endocrinol Metab 293: E237-245.
21. Young JM, Weser E (1971) The metabolism of circulating maltose in man. J Clin Invest 50: 986-991.